New User:
-or-
Username:
Password:
Forgot your password?
News Breaks
06:56 EDTDVAX
theflyonthewall.com: Dynavax Tech completes first patient enrollment in Phase 1b hepatitis B trial
Dynavax Technologies has completed enrollment for the first of three cohorts of patients receiving DV-601 hepatitis B therapy in a Phase 1b clinical trial. The safety profile of patients in the first cohort met pre-specified criteria for dose escalation and the second cohort has been opened for enrollment. Dynavax expects to report top-line data from this trial in the second half of 2010. DV-601 is the first hepatitis B therapy to combine both the surface and core HBV antigens, and Dynavax has retained all commercial rights to this product. :theflyonthewall.com



News For DVAX From The Last 14 Days
Check below for free stories on DVAX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2010
16:26 EDTDVAX
theflyonthewall.com: Dynavax Tech initiates large-scale phase 3 trial of Heplisav

Subscribe for More Information :theflyonthewall.com